[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.
about
Towards a global initiative for fibrosis treatment (GIFT).Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).Recommendations for perioperative management of lung cancer patients with comorbidities.Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics.
P2860
[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
[18F]FDG PET/CT predicts progr ...... idiopathic pulmonary fibrosis.
@ast
[18F]FDG PET/CT predicts progr ...... idiopathic pulmonary fibrosis.
@en
type
label
[18F]FDG PET/CT predicts progr ...... idiopathic pulmonary fibrosis.
@ast
[18F]FDG PET/CT predicts progr ...... idiopathic pulmonary fibrosis.
@en
prefLabel
[18F]FDG PET/CT predicts progr ...... idiopathic pulmonary fibrosis.
@ast
[18F]FDG PET/CT predicts progr ...... idiopathic pulmonary fibrosis.
@en
P2093
P2860
P1433
P1476
[18F]FDG PET/CT predicts progr ...... idiopathic pulmonary fibrosis.
@en
P2093
Arnaud Dieudonné
Astrid Laurent-Bellue
Aurélien Justet
Bruno Crestani
Gabriel Thabut
Marie-Pierre Debray
Rachida Lebtahi
Raphael Borie
P2860
P2888
P356
10.1186/S12931-017-0556-3
P577
2017-04-27T00:00:00Z
P6179
1084955824